Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...

We recently compiled a list of the The 10 Worst-Performing Stocks on Monday. In this article, we are going to take a look at ...

Preventing the cell's protein factories from making the notorious cancer-causing protein MYC could stop out-of-control tumors.

The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, ...

The center will operate as a consortium incorporating 17 research institutions, and no legal entity will be established ...

Modern medicine is helping clinicians tailor cancer treatments for individuals and Birmingham researchers are at the ...

Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

There are notable differences between men and women in their susceptibility to many human diseases, including cardiovascular ...

Pennsylvania State Senator Doug Mastriano (R-Franklin/Adams) announced he is introducing a bill that would ensure the state’s food remains free from unauthorized vaccines or ...

Goldman has recently reduced Moderna Inc (MRNA) stock to Neutral rating, as announced on January 29, 2025, according to Finviz. Earlier, on December 18, 2024, Argus had reduced the stock from a Buy to ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...